Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 87 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lexaria Bioscience Corporation | LEXX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.25 | 08:11:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.25 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 3 | 87 | - | 0.6488 - 6.85 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:11:17 | 75 | $ 2.26 | USD |
Lexaria Bioscience Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 10.28M | - | 226k | -6.67M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lexaria Bioscience News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LEXX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.64 | 2.73 | 1.85 | 2.20 | 326,463 | -0.39 | -14.77% |
| 1 Month | 3.44 | 4.00 | 1.85 | 2.97 | 250,518 | -1.19 | -34.59% |
| 3 Months | 1.50 | 6.85 | 1.36 | 3.54 | 521,570 | 0.75 | 50.00% |
| 6 Months | 1.04 | 6.85 | 0.9866 | 3.06 | 314,980 | 1.21 | 116.35% |
| 1 Year | 2.24 | 6.85 | 0.6488 | 2.42 | 221,742 | 0.01 | 0.45% |
| 3 Years | 5.06 | 12.50 | 0.6488 | 5.24 | 363,921 | -2.81 | -55.53% |
| 5 Years | 4.05 | 12.50 | 0.6488 | 5.30 | 352,956 | -1.80 | -44.44% |
Lexaria Bioscience Description
| Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio. |
